Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study - Concepedia

Concepedia

Publication | Open Access

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

DOI Full Paper Access

358

Citations

17

References

2020

Year

Robert L. Ferris, Robert I. Haddad, Caroline Even, Makoto Tahara, Mikhail Dvorkin, Tudor–Eliade Ciuleanu, Paul M. Clément, Lyubov Zholudeva, Amaury Daste, Javier Caballero-Daroqui,

Annals of Oncology

References

	Year	Citations

Page 1